Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Appropriate Antibiotic Use for Acute Otitis Media
Your Article Summary
Undertreatment of allergy: Exploring the utility of sublingual immunotherapy
Otolaryngology Head and Neck Surgery, 04/29/09
Emanuel IA et al. - Sublingual immunotherapy has been used extensively in Europe and possesses most of the benefits of subcutaneous immunotherapy along with increased safety, tolerability, and convenience. This narrative review explores data from selected clinical studies and concludes that sublingual immunotherapy may be well suited to fill the gap posed by the undertreatment of allergic syndromes in the United States.
Today in Allergy...keeping you current
Receive free subspecialty "5-minute updates" via email
Oral Allergy Syndrome
Allergology International, 10/30/09
Montelukast in the treatment of asthma and beyond
Expert Review of Clinical Immunology, 11/23/09
Clinical Studies of Combination Montelukast and Loratadine in Patients with Seasonal Allergic Rhinitis
Journal of Asthma, 11/11/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Saline Nasal Irrigation for Upper Respiratory Conditions
American Family Physician, 11/12/09
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
The Lancet Oncology - Online First, 11/12/09
Clinical Studies of Combination Montelukast and Loratadine in Patients with Seasonal Allergic Rhinitis
Journal of Asthma, 11/11/09
Article Search
Sponsor


See Latest Articles


